Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von TD Cowen 

Icon plc diskutieren

Icon plc

WKN: 932242 / Symbol: ICLR / Name: ICON / Aktie / Biotechnologie & medizinische Forschung / Mid Cap /

263,10 €
1,85 %

Einschätzung Buy
Rendite (%) -11,23 %
Kursziel 347,05
Veränderung
Endet am 08.07.25

ICON Public Limited (NASDAQ: ICLR) had its price target raised by analysts at Robert W. Baird from $367.00 to $376.00. They now have an "outperform" rating on the stock.
Ratings data for ICLR provided by MarketBeat

Einschätzung Buy
Rendite (%) -11,77 %
Kursziel 352,55
Veränderung
Endet am 26.07.25

ICON Public Limited (NASDAQ: ICLR) had its price target raised by analysts at Truist Financial Co. from $367.00 to $383.00. They now have a "buy" rating on the stock.
Ratings data for ICLR provided by MarketBeat

Einschätzung Buy
Rendite (%) -11,77 %
Kursziel 322,07
Veränderung
Endet am 26.07.25

ICON Public Limited (NASDAQ: ICLR) had its price target lowered by analysts at Barclays PLC from $355.00 to $350.00. They now have an "overweight" rating on the stock.
Ratings data for ICLR provided by MarketBeat

Einschätzung Buy
Rendite (%) 0,00 %
Kursziel 334,11
Veränderung
Endet am 11.09.25

ICON Public Limited (NASDAQ: ICLR) had its "outperform" rating re-affirmed by analysts at Robert W. Baird. They now have a $368.00 price target on the stock.
Ratings data for ICLR provided by MarketBeat

Einschätzung Buy
Rendite (%) 0,00 %
Kursziel 347,73
Veränderung
Endet am 11.09.25

ICON Public Limited (NASDAQ: ICLR) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $383.00 price target on the stock.
Ratings data for ICLR provided by MarketBeat